What does Lisata Therapeutics, Inc. do?
Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, engages in the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product is certepetide, which is in Phase 2 clinical studies for the treatment of solid tumors, such…
What is Lisata Therapeutics, Inc.'s P/E and P/B ratio?
Lisata Therapeutics, Inc. has a P/E ratio of -0.6 and a P/B ratio of 1.31.
What is Lisata Therapeutics, Inc.'s debt-to-equity ratio?
Lisata Therapeutics, Inc. has a debt-to-equity ratio of 0.00.
How much does Lisata Therapeutics, Inc. owe compared with what it owns?
Lisata Therapeutics, Inc. owes $0.28 for every $1 it owns (balance sheet Jun 2026), which is low.
What is Lisata Therapeutics, Inc.'s Positivity rank?
Lisata Therapeutics, Inc. is ranked #1,198 of 6,775 companies globally and #228 of 3,999 in United States on PositoAI, with a Positivity Score of 23,187.
Does Lisata Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for Lisata Therapeutics, Inc..
Where can I read the latest news about Lisata Therapeutics, Inc.?
Recent headlines about Lisata Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does Lisata Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of Lisata Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.